Bevacizumab 2 mg/0.08 mL in 3/10 mL recall: Particulate Matter
Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY…
Why was Bevacizumab 2 mg/0.08 mL in 3/10 mL recalled?
Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 1837@2, exp. 1/17/2016; 1646@6, exp. 12/20/2015
- Product
- Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY…
- Recalling firm
- Pine Pharmaceuticals, LLC
- Quantity
- N/A
- Distribution
- Nationwide and Puerto Rico
- Recall date
- January 27, 2016
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)